Free Trial

Star Equity (STRR) Competitors

Star Equity logo
$2.16 +0.02 (+0.70%)
As of 07/24/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

STRR vs. ALUR, IRIX, NXL, PETV, PSTV, RVP, OSRH, NRXS, NXGL, and IINN

Should you be buying Star Equity stock or one of its competitors? The main competitors of Star Equity include Allurion Technologies (ALUR), IRIDEX (IRIX), Nexalin Technology (NXL), PetVivo (PETV), Plus Therapeutics (PSTV), Retractable Technologies (RVP), OSR (OSRH), NeurAxis (NRXS), NexGel (NXGL), and Inspira Technologies OXY B.H.N. (IINN). These companies are all part of the "medical equipment" industry.

Star Equity vs. Its Competitors

Allurion Technologies (NYSE:ALUR) and Star Equity (NASDAQ:STRR) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends, earnings and media sentiment.

Star Equity has a net margin of -16.43% compared to Allurion Technologies' net margin of -86.05%. Allurion Technologies' return on equity of 0.00% beat Star Equity's return on equity.

Company Net Margins Return on Equity Return on Assets
Allurion Technologies-86.05% N/A -41.49%
Star Equity -16.43%-8.24%-3.48%

Allurion Technologies has a beta of -0.47, indicating that its share price is 147% less volatile than the S&P 500. Comparatively, Star Equity has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500.

21.4% of Allurion Technologies shares are owned by institutional investors. Comparatively, 3.8% of Star Equity shares are owned by institutional investors. 22.4% of Allurion Technologies shares are owned by company insiders. Comparatively, 33.5% of Star Equity shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Allurion Technologies presently has a consensus target price of $22.83, indicating a potential upside of 675.85%. Star Equity has a consensus target price of $5.00, indicating a potential upside of 130.95%. Given Allurion Technologies' higher probable upside, equities analysts plainly believe Allurion Technologies is more favorable than Star Equity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Allurion Technologies
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.00
Star Equity
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Star Equity has higher revenue and earnings than Allurion Technologies. Star Equity is trading at a lower price-to-earnings ratio than Allurion Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Allurion Technologies$32.11M0.68-$26.15M-$12.50-0.24
Star Equity$53.36M0.13-$10.44M-$3.43-0.63

In the previous week, Star Equity had 1 more articles in the media than Allurion Technologies. MarketBeat recorded 1 mentions for Star Equity and 0 mentions for Allurion Technologies. Star Equity's average media sentiment score of 1.89 beat Allurion Technologies' score of 0.00 indicating that Star Equity is being referred to more favorably in the news media.

Company Overall Sentiment
Allurion Technologies Neutral
Star Equity Very Positive

Summary

Star Equity beats Allurion Technologies on 9 of the 16 factors compared between the two stocks.

Get Star Equity News Delivered to You Automatically

Sign up to receive the latest news and ratings for STRR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STRR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STRR vs. The Competition

MetricStar EquityDIVERSIFIED OPS IndustryMulti-Sector SectorNASDAQ Exchange
Market Cap$6.90M$16.37B$15.00B$9.47B
Dividend YieldN/A4.17%3.95%3.99%
P/E Ratio-0.638.907.5519.95
Price / Sales0.134.613.85100.89
Price / Cash6.6033.7732.3858.97
Price / Book0.202.322.045.90
Net Income-$10.44M$951.84M$922.55M$258.42M
7 Day Performance9.07%2.99%2.97%2.11%
1 Month Performance10.46%8.09%6.35%12.44%
1 Year Performance-55.82%-2.37%-2.57%19.55%

Star Equity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
STRR
Star Equity
3.6356 of 5 stars
$2.17
+0.7%
$5.00
+130.9%
-55.1%$6.90M$53.36M-0.63460High Trading Volume
ALUR
Allurion Technologies
3.0033 of 5 stars
$3.13
-2.0%
$22.83
+630.7%
-86.4%$23.31M$32.11M-0.25501
IRIX
IRIDEX
0.517 of 5 stars
$1.33
+5.2%
N/A-34.0%$22.25M$48.67M-3.08120High Trading Volume
NXL
Nexalin Technology
3.0767 of 5 stars
$1.24
+3.7%
$5.00
+301.9%
+0.8%$21.37M$170K-1.503Positive News
PETV
PetVivo
N/A$0.84
+0.7%
N/A+29.1%$20.44M$1.05M-1.8620
PSTV
Plus Therapeutics
1.7484 of 5 stars
$0.40
+3.4%
$10.83
+2,628.8%
-65.9%$20.25MN/A-0.1420Gap Up
RVP
Retractable Technologies
2.1107 of 5 stars
$0.67
+1.3%
N/A-35.3%$20.15M$33.75M-1.25240
OSRH
OSR
N/A$1.04
-3.7%
N/AN/A$20.05MN/A0.00N/ANews Coverage
Gap Up
NRXS
NeurAxis
2.5584 of 5 stars
$2.69
-1.6%
$7.00
+160.7%
-14.6%$19.38M$2.93M-1.4619
NXGL
NexGel
0.9991 of 5 stars
$2.45
+2.3%
N/A-15.9%$18.70M$8.69M-5.4310
IINN
Inspira Technologies OXY B.H.N.
1.7428 of 5 stars
$1.38
+6.2%
$2.00
+44.9%
+31.2%$17.42MN/A0.0020

Related Companies and Tools


This page (NASDAQ:STRR) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners